Battered markets have a new thing to worry about: the possibility of a socialist US president, our monthly outlook warns.
Bernie Sanders has so far done surprisingly well in the race for the Democratic Party nomination to challenge US President Trump in the November election. The 78-year-old senator is by far the most left-wing candidate to challenge for the position in decades.
“In 2019, the main risks to the macro outlook for investors were the trade wars, the global industrial recession and major central bank easing/tightening – issues that are known unknowns,” says Regina Borromeo, Senior Portfolio Manager and Director of Global Macro at Robeco. “For 2020, they are the global spread of Covid-19 and the possibility of a Bernie Sanders presidency.”
“Sanders is an anti-establishment politician and, in many ways, an outsider and disruptor. Since losing out to Hillary Clinton for the nomination in 2016, he has sharpened his process and campaign machine to build a strong base among previously undervalued groups such as young people and Latino voters.”
“Whilst the market base case assumption has been a continuation of the status quo – a Republican President (Trump), a Republican-led Senate and a Democratic majority in the House of Representatives – this time around, Sanders may finally have learned how to win!”
Sanders’ main rival is former Vice-President Joe Biden, who did well in the ‘Super Tuesday’ primary polls across 14 states and is much more moderate. “Establishment Democrats are unsure that Sanders’ brand of democratic socialism can win the national vote, since he is much more left-wing than the average American,” Borromeo says.
“Furthermore, long-standing Democrats are wary of insurgent candidates such as Sanders, since he ran as an independent for his Vermont Senate seat, and is only running as a Democrat for the presidential elections. However, his high-energy anti-establishment and socialist messaging against big business and the wealthy has certainly gained traction, whilst the moderate vote has remained fractured.”
“The share of eligible voters from Generation Z (18 to 23-year-olds) will be more than twice as large in 2020 as it was in 2016 (10% versus 4%), which could be beneficial for Sanders. President Trump has shown that political dominance and anti-establishment behavior can win. Sanders would need to mobilize an unprecedented youth vote and expand the electorate to win the Democratic nomination, as well as to beat Trump.”
So, what does Sanders advocate in such a staunchly capitalist country? “A highlight of Sanders’ campaign is social inequality, and certain policy items focus on this, such as forgiving student debt, free tuition in state universities, a series of tax increases, an increase in the minimum wage to USD 15 per hour, and universal free health care,” says Borromeo.
“These will be popular among many Americans, but some of his policy priorities are unfavorable for markets.” She says four policies in particular could hammer the markets:
The sectors most directly affected would therefore be pharmaceuticals, health care and banks, Borromeo says. However, investors should bear in mind that Congressional elections will also take place in November, posing problems for whoever becomes president.
“The two most likely scenarios are either a split Congress – with Democrats controlling the House of Representatives and Republicans controlling the Senate, as in the current situation – or a simple but weak majority by the Democrats controlling both,” she says.
“In both scenarios, it would be difficult for Sanders to pass most of his signature policies such as Medicare for All, breaking up the banks, his full tax plans and all student debt forgiven,” says Borromeo. “Congressional Democrats would need a united front to pass sweeping legislation against widespread Republican opposition, which would be a high hurdle for many of the controversial Sanders policies.”
So, what does this mean for a market being battered by the coronavirus? “A Sanders candidacy turning into a successful run for the presidency will add to the risk-off sentiment and volatility, given his anti-big business views, focus on financial regulation and restrictive tax plans,” Borromeo says.
“Medicare for All would have a high material negative impact on pharmaceutical, dialysis and medical device names, along with health care insurance. And it would have a moderately negative impact on medical equipment and supplies. With increases in volatility, idiosyncratic opportunities will arise though and give value investors the ability to pick winners and losers.”
“Perhaps the final word should rest with John Adams, a founding father of the United States, who served as the second president from 1797 to 1801. He wrote in a letter on 23 March 1776: ‘In politics, the middle way is none at all.’ Both Trump and Sanders have certainly not taken that path.”
The Robeco Capital Growth Funds have not been registered under the United States Investment Company Act of 1940, as amended, nor or the United States Securities Act of 1933, as amended. None of the shares may be offered or sold, directly or indirectly in the United States or to any U.S. Person (within the meaning of Regulation S promulgated under the Securities Act of 1933, as amended (the “Securities Act”)). Furthermore, Robeco Institutional Asset Management B.V. (Robeco) does not provide investment advisory services, or hold itself out as providing investment advisory services, in the United States or to any U.S. Person (within the meaning of Regulation S promulgated under the Securities Act).
This website is intended for use only by non-U.S. Persons outside of the United States (within the meaning of Regulation S promulgated under the Securities Act who are professional investors, or professional fiduciaries representing such non-U.S. Person investors. By clicking “I Agree” on our website disclaimer and accessing the information on this website, including any subdomain thereof, you are certifying and agreeing to the following: (i) you have read, understood and agree to this disclaimer, (ii) you have informed yourself of any applicable legal restrictions and represent that by accessing the information contained on this website, you are not in violation of, and will not be causing Robeco or any of its affiliated entities or issuers to violate, any applicable laws and, as a result, you are legally authorized to access such information on behalf of yourself and any underlying investment advisory client, (iii) you understand and acknowledge that certain information presented herein relates to securities that have not been registered under the Securities Act, and may be offered or sold only outside the United States and only to, or for the account or benefit of, non-U.S. Persons (within the meaning of Regulation S under the Securities Act), (iv) you are, or are a discretionary investment adviser representing, a non-U.S. Person (within the meaning of Regulation S under the Securities Act) located outside of the United States and (v) you are, or are a discretionary investment adviser representing, a professional non-retail investor. Access to this website has been limited so that it shall not constitute directed selling efforts (as defined in Regulation S under the Securities Act) in the United States and so that it shall not be deemed to constitute Robeco holding itself out generally to the public in the U.S. as an investment adviser. Nothing contained herein constitutes an offer to sell securities or solicitation of an offer to purchase any securities in any jurisdiction. We reserve the right to deny access to any visitor, including, but not limited to, those visitors with IP addresses residing in the United States.
This website has been carefully prepared by Robeco. The information contained in this publication is based upon sources of information believed to be reliable. Robeco is not answerable for the accuracy or completeness of the facts, opinions, expectations and results referred to therein. Whilst every care has been taken in the preparation of this website, we do not accept any responsibility for damage of any kind resulting from incorrect or incomplete information. This website is subject to change without notice. The value of the investments may fluctuate. Past performance is no guarantee of future results. If the currency in which the past performance is displayed differs from the currency of the country in which you reside, then you should be aware that due to exchange rate fluctuations the performance shown may increase or decrease if converted into your local currency. For investment professional use only. Not for use by the general public.